These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 29305275)

  • 81. Patients with moyamoya disease presenting with movement disorder.
    Pandey P; Bell-Stephens T; Steinberg GK
    J Neurosurg Pediatr; 2010 Dec; 6(6):559-66. PubMed ID: 21121731
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Machine learning models of ischemia/hemorrhage in moyamoya disease and analysis of its risk factors.
    Chen Z; Luo H; Xu L
    Clin Neurol Neurosurg; 2021 Oct; 209():106919. PubMed ID: 34507124
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Significance of cyclooxygenase-2 elevation in middle cerebral artery for patients with hemorrhagic moyamoya disease.
    Zhang JJ; Xiong ZW; Wang S; Sun SJ; Wang H; Wu XL; Wang L; Zhang HQ; You C; Wang Y; Chen JC
    J Huazhong Univ Sci Technolog Med Sci; 2016 Apr; 36(2):181-185. PubMed ID: 27072959
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Coexisting diseases of moyamoya vasculopathy.
    Wei YC; Liu CH; Chang TY; Chin SC; Chang CH; Huang KL; Chang YJ; Peng TI; Lee TH
    J Stroke Cerebrovasc Dis; 2014 Jul; 23(6):1344-50. PubMed ID: 24468071
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Familial occurrence of moyamoya disease: a clinical study.
    Seol HJ; Wang KC; Kim SK; Hwang YS; Kim KJ; Cho BK
    Childs Nerv Syst; 2006 Sep; 22(9):1143-8. PubMed ID: 16565850
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Headache in pediatric moyamoya disease: review of 204 consecutive cases.
    Seol HJ; Wang KC; Kim SK; Hwang YS; Kim KJ; Cho BK
    J Neurosurg; 2005 Nov; 103(5 Suppl):439-42. PubMed ID: 16302616
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Progress on Complications of Direct Bypass for Moyamoya Disease.
    Yu J; Shi L; Guo Y; Xu B; Xu K
    Int J Med Sci; 2016; 13(8):578-87. PubMed ID: 27499690
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Effective surgical revascularization improves cerebral hemodynamics and resolves headache in pediatric Moyamoya disease.
    Kawabori M; Kuroda S; Nakayama N; Hirata K; Shiga T; Houkin K; Tamaki N
    World Neurosurg; 2013 Nov; 80(5):612-9. PubMed ID: 23022638
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Microembolic signals predict cerebral ischaemic events in patients with moyamoya disease.
    Chen J; Duan L; Xu WH; Han YQ; Cui LY; Gao S
    Eur J Neurol; 2014 May; 21(5):785-90. PubMed ID: 24602165
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Moyamoya syndrome causing stroke in young women with type 1 diabetes.
    Hughes JW; Wyckoff JA; Hollander AS; Derdeyn CP; McGill JB
    J Diabetes Complications; 2016; 30(8):1640-1642. PubMed ID: 27592246
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Prevalence of asymptomatic microbleeds in patients with moyamoya disease.
    Ishikawa T; Kuroda S; Nakayama N; Terae S; Kudou K; Iwasaki Y
    Neurol Med Chir (Tokyo); 2005 Oct; 45(10):495-500; discussion 500. PubMed ID: 16247234
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Smoke exposure is associated with a lower prevalence of serum thyroid autoantibodies and thyrotropin concentration elevation and a higher prevalence of mild thyrotropin concentration suppression in the third National Health and Nutrition Examination Survey (NHANES III).
    Belin RM; Astor BC; Powe NR; Ladenson PW
    J Clin Endocrinol Metab; 2004 Dec; 89(12):6077-86. PubMed ID: 15579761
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Moyamoya disease in Brazil.
    Minelli C; Takayanagui OM; dos Santos AC; Fabio SC; Lima JE; Sato T; Colli BO
    Acta Neurol Scand; 1997 Feb; 95(2):125-8. PubMed ID: 9059734
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Follow-up study of patients with "unilateral" moyamoya disease.
    Kawano T; Fukui M; Hashimoto N; Yonekawa Y
    Neurol Med Chir (Tokyo); 1994 Nov; 34(11):744-7. PubMed ID: 7533268
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Epidemiology of Moyamoya Disease in China: Single-Center, Population-Based Study.
    Bao XY; Wang QN; Zhang Y; Zhang Q; Li DS; Yang WZ; Zhang ZS; Zong R; Han C; Duan L
    World Neurosurg; 2019 Feb; 122():e917-e923. PubMed ID: 30404059
    [TBL] [Abstract][Full Text] [Related]  

  • 96. A Retrospective Study on Clinical Features of Childhood Moyamoya Disease.
    Wang Y; Kong H; Wang Y; Jin P; Ding J; Li H; Wang H; Zhuo Z
    Pediatr Neurol; 2023 Jan; 138():17-24. PubMed ID: 36335837
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Inheritance of moyamoya disease in a Caucasian family.
    Kraemer M; Heinemann FM; Horn PA; Venker C; Berlit P; Krischek B; Khan N
    Eur J Neurol; 2012 Mar; 19(3):438-42. PubMed ID: 21974719
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Clinical Presentation and Stroke Incidence Differ by Moyamoya Etiology.
    Gatti JR; Torriente AG; Sun LR
    J Child Neurol; 2021 Mar; 36(4):272-280. PubMed ID: 33155871
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Moyamoya vasculopathy with anti-SCL-70 antibodies: A case report and review of the literature.
    Ahmad AS; Tahir RA; Mitsias PD
    J Clin Neurosci; 2018 Oct; 56():177-179. PubMed ID: 30017593
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Prospective evaluation of the diagnostic value of plasma apelin 12 levels for differentiating patients with moyamoya and intracranial atherosclerotic diseases.
    Hu W; Jiang W; Ye L; Tian Y; Shen B; Wang K
    Sci Rep; 2017 Jul; 7(1):5452. PubMed ID: 28710384
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.